High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
Intrepid Potash (IPI) delivered earnings and revenue surprises of +47.37% and +0.52%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Intuit downgrade, Intuitive Surgical upgraded: Wall Street's top analyst calls
Recent price move puts Nutrien in the spotlight Nutrien (TSX:NTR) moved higher on July 13, 2026, with the stock gaining 3.3% to $67.60. This price action has brought fresh attention to its valuation and the balance between recent momentum and underlying fundamentals. See our latest analysis for Nutrien. That single day move in Nutrien comes on top of a 7 day share price return of 4.1% and a year to date share price return of 11.2%. The 1 year total shareholder return of 21.4% indicates recent...
Is NTR a good stock to buy? We came across a bullish thesis on Nutrien Ltd. on X.com by @MoneyShow. In this article, we will summarize the bulls’ thesis on NTR. Nutrien Ltd.’s share was trading at $67.28 as of June 8th. NTR’s trailing and forward P/E were 13.69 and 11.68 respectively according to Yahoo Finance. Nutrien […]
CF has surged nearly 50% in six months as strong nitrogen demand and higher prices fuel earnings growth.
Investors who take an interest in Nutrien Ltd. ( TSE:NTR ) should definitely note that the Non-Independent Director...
Investors may be wondering whether Nutrien's share price still offers solid value, or if most of the opportunity has already been priced in. The stock most recently closed at US$93.29, with returns of 7.5% year to date and 26.8% over the last year, even after a 9.6% move over 7 days and a 12.8% shift over 30 days. Recent coverage has focused on how Nutrien fits into broader materials and agriculture themes, as investors reassess exposure to fertilizer producers and related businesses. That...
NTR beat Q1 earnings estimates as record potash volumes, stronger pricing and Retail demand lifted earnings and sales sharply year over year.
CF stock heads into Q1 earnings with rising estimates, strong nitrogen demand and pricing tailwinds.
LIN's bottom line beat Q1 estimates as pricing and project start-ups drive growth, with revenues up 8% and EPS rising 10% year over year.
Nutrien (NTR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.